APA

Kopić A., Benamara K., Piskernik C., Plaimauer B., Horling F., Höbarth G., Ruthsatz T., Dietrich B., Muchitsch E., Scheiflinger F., Turecek M. & Höllriegl W. (20180108). Preclinical assessment of a new recombinant ADAMTS-13 drug product (BAX930) for the treatment of thrombotic thrombocytopenic purpura. : Journal of thrombosis and haemostasis : JTH.

Chicago

Kopić A, Benamara K, Piskernik C, Plaimauer B, Horling F, Höbarth G, Ruthsatz T, Dietrich B, Muchitsch E-M, Scheiflinger F, Turecek M and Höllriegl W. 20180108. Preclinical assessment of a new recombinant ADAMTS-13 drug product (BAX930) for the treatment of thrombotic thrombocytopenic purpura. : Journal of thrombosis and haemostasis : JTH.

Harvard

Kopić A., Benamara K., Piskernik C., Plaimauer B., Horling F., Höbarth G., Ruthsatz T., Dietrich B., Muchitsch E., Scheiflinger F., Turecek M. and Höllriegl W. (20180108). Preclinical assessment of a new recombinant ADAMTS-13 drug product (BAX930) for the treatment of thrombotic thrombocytopenic purpura. : Journal of thrombosis and haemostasis : JTH.

MLA

Kopić A, Benamara K, Piskernik C, Plaimauer B, Horling F, Höbarth G, Ruthsatz T, Dietrich B, Muchitsch E-M, Scheiflinger F, Turecek M and Höllriegl W. Preclinical assessment of a new recombinant ADAMTS-13 drug product (BAX930) for the treatment of thrombotic thrombocytopenic purpura. : Journal of thrombosis and haemostasis : JTH. 20180108.